Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan.

Sarwar MR, Atif M, Scahill S, Saqib A, Qamar-Uz-Zaman M, Babar Z.

J Pharm Policy Pract. 2017 Aug 4;10:23. doi: 10.1186/s40545-017-0112-z. eCollection 2017.

2.

Beta-1 vs. beta-2 adrenergic control of coronary blood flow during isometric handgrip exercise in humans.

Maman SR, Vargas AF, Ahmad TA, Miller AJ, Gao Z, Leuenberger UA, Proctor DN, Muller MD.

J Appl Physiol (1985). 2017 Aug 1;123(2):337-343. doi: 10.1152/japplphysiol.00106.2017. Epub 2017 Jun 1.

PMID:
28572492
3.

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.

Dondo TB, Hall M, West RM, Jernberg T, Lindahl B, Bueno H, Danchin N, Deanfield JE, Hemingway H, Fox KAA, Timmis AD, Gale CP.

J Am Coll Cardiol. 2017 Jun 6;69(22):2710-2720. doi: 10.1016/j.jacc.2017.03.578.

4.

Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials.

Mengesha HG, Weldearegawi B, Petrucka P, Bekele T, Otieno MG, Hailu A.

BMC Cardiovasc Disord. 2017 Apr 28;17(1):105. doi: 10.1186/s12872-017-0540-3.

5.

Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium.

Quan Z, Wang QL, Zhou P, Wang GD, Tan YZ, Wang HJ.

Int J Mol Med. 2017 Jun;39(6):1347-1356. doi: 10.3892/ijmm.2017.2950. Epub 2017 Apr 11.

6.

Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.

Dong YH, Alcusky M, Maio V, Liu J, Liu M, Wu LC, Chang CH, Lai MS, Gagne JJ.

BMJ Open. 2017 Mar 31;7(3):e012997. doi: 10.1136/bmjopen-2016-012997.

7.

Higher incidence of hypotension episodes in women during the sub-acute phase of ST elevation myocardial infarction and relationship to covariates.

Kala P, Novotny T, Andrsova I, Benesova K, Holicka M, Jarkovsky J, Hnatkova K, Koc L, Mikolaskova M, Novakova T, Ondrus T, Privarova L, Spinar J, Malik M.

PLoS One. 2017 Mar 9;12(3):e0173699. doi: 10.1371/journal.pone.0173699. eCollection 2017.

8.

Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease.

Tsujimoto T, Sugiyama T, Kajio H.

Diabetes Obes Metab. 2017 Jun;19(6):800-808. doi: 10.1111/dom.12878. Epub 2017 Feb 17.

9.

Mortality reduction with use of oral beta-blockers in patients with acute coronary syndrome.

de Matos Soeiro A, de Barros E Silva PG, Roque EA, Bossa AS, Zullino CN, Simões SA, Okada MY, Leal TC, Soeiro MC, Serrano CV Jr, Oliveira MT Jr.

Clinics (Sao Paulo). 2016 Nov 1;71(11):635-638. doi: 10.6061/clinics/2016(11)03.

10.

Beta-Blocker Use in U.S. Nursing Home Residents After Myocardial Infarction: A National Study.

Zullo AR, Lee Y, Daiello LA, Mor V, John Boscardin W, Dore DD, Miao Y, Fung KZ, Komaiko KDR, Steinman MA.

J Am Geriatr Soc. 2017 Apr;65(4):754-762. doi: 10.1111/jgs.14671. Epub 2016 Nov 15.

PMID:
27861719
11.
12.

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.

Puymirat E, Riant E, Aissoui N, Soria A, Ducrocq G, Coste P, Cottin Y, Aupetit JF, Bonnefoy E, Blanchard D, Cattan S, Steg G, Schiele F, Ferrières J, Juillière Y, Simon T, Danchin N.

BMJ. 2016 Sep 20;354:i4801. doi: 10.1136/bmj.i4801.

13.

Acute myocardial infarction in the obstetric patient.

Firoz T, Magee LA.

Obstet Med. 2012 Jun;5(2):50-7. doi: 10.1258/om.2011.011080. Epub 2012 Mar 22. Review.

14.

Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis.

Tolla MT, Norheim OF, Memirie ST, Abdisa SG, Ababulgu A, Jerene D, Bertram M, Strand K, Verguet S, Johansson KA.

Cost Eff Resour Alloc. 2016 Aug 12;14:10. doi: 10.1186/s12962-016-0059-y. eCollection 2016.

15.

Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion.

Hwang JK, Yang JH, Hwang JW, Jang WJ, Song YB, Hahn JY, Choi JH, Lee SH, Gwon HC, Choi SH.

Medicine (Baltimore). 2016 Jul;95(30):e4300. doi: 10.1097/MD.0000000000004300.

16.

Chronic β1-adrenoceptor blockade impairs ischaemic tolerance and preconditioning in murine myocardium.

See Hoe LE, Schilling JM, Busija AR, Haushalter KJ, Ozberk V, Keshwani MM, Roth DM, Toit ED, Headrick JP, Patel HH, Peart JN.

Eur J Pharmacol. 2016 Oct 15;789:1-7. doi: 10.1016/j.ejphar.2016.06.054. Epub 2016 Jun 30.

PMID:
27373851
17.

Effect of early bisoprolol administration on ventricular arrhythmia and cardiac death in patients with non-ST elevation myocardial infarction.

Maclean E, Zheng S, Nabeebaccus A, O'Gallagher K, Stewart A, Webb I.

Heart Asia. 2015 Nov 30;7(2):46-51. doi: 10.1136/heartasia-2015-010675. eCollection 2015.

18.

Initiation of β-blocker therapy and depression after acute myocardial infarction.

Ranchord AM, Spertus JA, Buchanan DM, Gosch KL, Chan PS.

Am Heart J. 2016 Apr;174:37-42. doi: 10.1016/j.ahj.2015.11.018. Epub 2015 Dec 17.

19.

Effect of Beta Blockers and Renin-Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Lee PH, Park GM, Kim YH, Yun SC, Chang M, Roh JH, Yoon SH, Ahn JM, Park DW, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

Medicine (Baltimore). 2016 Mar;95(10):e2971. doi: 10.1097/MD.0000000000002971.

20.

Contribution of Hepatitis B to Long-Term Outcome Among Patients With Acute Myocardial Infarction: A Nationwide Study.

Kuo PL, Lin KC, Tang PL, Cheng CC, Huang WC, Chiang CH, Lin HC, Chuang TJ, Wann SR, Mar GY, Cheng JS, Liu CP.

Medicine (Baltimore). 2016 Feb;95(5):e2678. doi: 10.1097/MD.0000000000002678.

Supplemental Content

Support Center